Gallstone disease: primary and secondary prevention

被引:29
作者
Venneman, Niels G. [1 ]
van Erpecum, Karel J.
机构
[1] Univ Med Ctr Utrecht, Dept Gastroenterol, Gastrointestinal Res Unit, Utrecht, Netherlands
[2] St Antonius Hosp, Dept Internal Med, NL-3430 EM Nieuwegein, Netherlands
关键词
acute cholecystitis; acute pancreatitis; choledocholithiasis; gallbladder; gallstone; prevention; UDCA;
D O I
10.1016/j.bpg.2006.03.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Several risk factors for cholesterol gallstone formation in the general population have been identified. There is a strongly increased risk of gallstone disease during prolonged fasting, rapid weight loss, total parenteral nutrition, and somatostati n (-analogue) treatment. The annual risk of biliary colic and gallstone complications in asymptomatic gallstone carriers has been investigated sparsely. In asymptomatic and symptomatic gallstone carriers, treatment with the hydrophilic bile salt ursocleoxycholic acid (UDCA) has been claimed to reduce the risk of biliary colic and gallstone complications such as acute cholecystitis and acute pancreatitis. Also, prophylactic cholecystectomy could be beneficial in certain subgroups of asymptomatic gallstone carriers. However, randomized, double-blind, placebo-controlled trials are lacking. In this review, strategies for the prevention of gallstone formation in the general population and in high-risk conditions are dealt with. Also, strategies for the prevention of biliary colic and gallstone complications in asymptomatic and symptomatic gallstone carriers are discussed.
引用
收藏
页码:1063 / 1073
页数:11
相关论文
共 95 条
[1]   Treatment of biliary colic with diclofenac: A randomized, double-blind, placebo-controlled study [J].
Akriviadis, EA ;
Hatzigavriel, M ;
Kapnias, D ;
Kirimlidis, J ;
Markantas, A ;
Garyfallos, A .
GASTROENTEROLOGY, 1997, 113 (01) :225-231
[2]   Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obesity [J].
Al-Jiffry, BO ;
Shaffer, EA ;
Saccone, GTP ;
Downey, P ;
Kow, L ;
Toouli, J .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (03) :169-174
[3]  
Al-Waili N, 1998, Eur J Med Res, V3, P475
[4]   SPINAL-CORD INJURY IS A RISK FACTOR FOR GALLSTONE DISEASE [J].
APSTEIN, MD ;
DALECKICHIPPERFIELD, K .
GASTROENTEROLOGY, 1987, 92 (04) :966-968
[5]   Pathogenesis of cholesterol gallstones: A parsimonious hypothesis [J].
Apstein, MD ;
Carey, MC .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (05) :343-352
[6]  
ATTILI AF, 1988, HEPATOLOGY, V8, P904
[7]  
Avila NA, 1998, J CLIN ULTRASOUND, V26, P289, DOI 10.1002/(SICI)1097-0096(199807/08)26:6<289::AID-JCU2>3.0.CO
[8]  
2-E
[9]   URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHOLESTEROL CHOLELITHIASIS .1. [J].
BACHRACH, WH ;
HOFMANN, AF .
DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (08) :737-761
[10]   A POPULATION STUDY ON THE PREVALENCE OF GALLSTONE DISEASE - THE SIRMIONE STUDY [J].
BARBARA, L ;
SAMA, C ;
LABATE, AMM ;
TARONI, F ;
RUSTICALI, AG ;
FESTI, D ;
SAPIO, C ;
RODA, E ;
BANTERLE, C ;
PUCI, A ;
FORMENTINI, F ;
COLASANTI, S ;
NARDIN, F .
HEPATOLOGY, 1987, 7 (05) :913-917